Generation Bio

Manufacturing · Massachusetts, United States · 150 Employees

Founded in 2016 and headquartered in Cambridge, Massachusetts, Generation Bio a biotechnology company developing a breakthrough class of genetic medicines to enable a new generation of people unaffected by inherited disease.Read More

Contact

Who is Generation Bio

Headquarters

301 Binney St, Cambridge, Massachusetts, 02142, United States

Phone Number

(617) 655-7500

Website

www.generationbio.com

Revenue

$50.6M

Stock Symbol

GBIO

Industry

Pharmaceuticals

Is this data correct?

View contact profiles from Generation Bio

Popular Searches

Generation bio

Generation Bio Co

Generation Pharmacy Group, L

Generation Ii Inc

Generation Bio Securities Corp

SIC Code 28,283

NAICS Code 32,325

Ticker NASDAQ: GBIO

Top Competitors of Generation Bio

Adverum Biotechnologies
188
$7.5M
1
Sigilon Therapeutics Inc
66
$11.4M
2
Beam Therapeutics Inc
394
$60.3M
3
Akouos
103
$34.8M
4
Vor Biopharma Inc
135
$45.6M
5
Editas Medicine
264
$25.8M
6

Generation Bio Org Chart

Geoff Mcdonough

President & Chief Executive ...

Phone

Email

Matthew Norkunas

Chief Financial Officer

Phone

Email

Antoinette Paone

Chief Operating Officer

Phone

Email

Phone

Email

View Email Formats for Generation Bio

Generation Bio Company Metrics

Company Insights

Employee Growth Rate

Funding

Funding DateJan 10, 2020

RoundSeries C

Amount$110M

InvestorsDeerfield, Atlas Venture, Casdin, T. Rowe Price, Farallon, Foresite Capital, Wellington Management Company, Fidelity, Invus

Funding DateFeb 27, 2018

RoundSeries B

Amount$100M

Investors

Funding DateDec 01, 2016

RoundSeries A

Amount$25M

Investors

See More

$235M

Total Funding Amount

$110M

Most Recent Funding Amount

3

Number of Funding Rounds

Generation Bio News & Media

Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Collaboration will extend the applications of each company’s platform through discovery and development of novel lipid nanoparticles using Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system
Mar 23, 2023
www.globenewswire.com
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in the Gene Therapy panel discussion at the 43rd Annual Cowen Healthcare Conference on Monday, March 6th at 10:30 a.m. EST in Boston, MA.
Feb 27, 2023
www.globenewswire.com
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
— Company expects to announce data for Factor VIII expression in non-human primates in 2023
Feb 23, 2023
www.globenewswire.com
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th at 4:30 p.m. PST in San Francisco, CA. A live webcast of the company presentation will be available on the investor section of the company website at investors.generationbio.com. About Generation Bio
Jan 3, 2023
finance.yahoo.com
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell & Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York.
Sep 22, 2022
www.globenewswire.com

Frequently Asked Questions regarding Generation Bio

Where is Generation Bio located?

Generation Bio's headquarters are located at 301 Binney St, Cambridge, Massachusetts, 02142, United States

What is Generation Bio's phone number?

Generation Bio's phone number is (617) 655-7500

What is Generation Bio's stock symbol?

Generation Bio's stock symbol is GBIO

What is Generation Bio's official website?

Generation Bio's official website is www.generationbio.com

What is Generation Bio's Revenue?

Generation Bio's revenue is $50.6 Million

What is Generation Bio's SIC code?

Generation Bio's SIC: 28,283

What is Generation Bio's NAICS code?

Generation Bio's NAICS: 32,325

How many employees does Generation Bio have?

Generation Bio has 150 employees

What industry does Generation Bio belong to?

Generation Bio is in the industry of: Pharmaceuticals, Healthcare

What is Generation Bio competition?

Generation Bio top competitors include: Adverum Biotechnologies, Sigilon Therapeutics Inc, Beam Therapeutics Inc, Akouos

Who is the CEO of Generation Bio?

Generation Bio's CEO is Geoff Mcdonough

Who is the CFO of Generation Bio?

Generation Bio's CFO is Matthew Norkunas

How do I contact Generation Bio?

Generation Bio contact info: Phone number: (617) 655-7500 Website: www.generationbio.com

What does Generation Bio do?

Founded in 2016 and headquartered in Cambridge, Massachusetts, Generation Bio a biotechnology company developing a breakthrough class of genetic medicines to enable a new generation of people unaffected by inherited disease.... Read More

What are Generation Bio social media links?

Generation Bio Linkedin page Generation Bio Twitter page

How much funding has Generation Bio raised to date?

Generation Bio has raised $235 Million in 3 funding rounds

When was the last funding round for Generation Bio?

Generation Bio closed its last funding round on Jan 10, 2020 with the amount of $110 Million

Who invested in Generation Bio?

Generation Bio has 11 investors including Foresite Capital, Wellington Management Company, Fidelity and Invus.

Is Generation Bio a public company?

Yes, Generation Bio is a public company and is traded under the symbol GBIO

See more information about Generation Bio

Trending Intent Signals iIntent topics are topics that prospects are actively searching for online.

Find out what Generation Bio is actively searching across the web.

Topic

Signal Score

Cloud Migration

100

3 Signals found

Signal Location

South America

Date

3/22/23

Score

Audience

Generation Bio Search Intents

Data Analytics

74

4 Signals found

Signal Location

Asia

Date

3/22/23

Score

Audience

Generation Bio Search Intents

Get Full Access

Join the world's top companies using Zoominfo

4.4/5 on G2 Crowd

You're signed out.

Sign in to ZoomInfo to uncover contact details.

Boston New York City Houston Chicago Los Angeles Atlanta

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Boston New York City Houston Chicago Los Angeles Atlanta